Abstract

Background: Castleman disease (CD) is a rare and heterogeneous lymphoproliferative disorder with a wide variety of clinical presentations and outcomes. Human herpesvirus-8 (HHV-8) related CD corresponds to the most common subtype of the multicentric Castleman disease (MCD). However, if HHV-8 is negative, POEMS (peripheral neuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes) associated with MCD or idiopathic MCD are the cause in a subgroup of patients. Considering the rarity of POEMS and MCD association, we herein describe a patient with a typical presentation based on clinical, laboratory and tissue biopsy data. Case Presentation: We report a diabetic patient who presented with asthenia, edema, skin lesions manifested by scarring in chiropodactyls, multiple lymph node enlargement in the neck, armpits and inguinal areas, splenomegaly, severe anemia, thrombocytopenia, and mixed polyneuropathy. Hematuria and proteinuria were detected. The patient developed progressive renal failure requiring dialysis. Renal biopsy showed mesangial expansion with mesangial hypercellularity, and lymphoplasmacytoid cells focally distributed in tubules and interstitium, which were compatible with acute tubulointerstitial nephritis. In immunofluorescence, no deposits of IgG, IgA, IgM, C1q, C3 or fibrinogen were found, and kappa and lambda were also negative. Lymph node biopsy revealed lymphoid tissue with follicular hyperplasia, sinusoidal and medullary infiltration of plasma cells. Immunohistochemistry confirmed positivity for B lymphocytes, T lymphocytes, and plasma cells in sub-capsular and para-follicular areas. The patient was diagnosed as POEMS-associated MCD variant, and chemotherapy with cyclophosphamide, doxorubicin, vincristine, and prednisone was started. The patient did not recover renal function and remained dialysis-dependent. Conclusions: To date, the renal involvement in MCD and POEMS syndrome seems to be uncommon as reported in few case series. Its pathophysiology is not well understood. In the spectrum of MCD, decreased renal function may have impact in patient survival. Early diagnosis and treatment are needed to control the systemic manifestations, and most importantly to avoid chronic organ damage.

Highlights

  • Castleman disease (CD) is a rare and heterogeneous lymphoproliferative disorder with a wide variety of clinical presentations and outcomes

  • multicentric Castleman disease (MCD) presents with fever, asthenia, pleural effusion, ascites, multiple lymph nodes, and hepatosplenomegaly, and unicentric CD (UCD) with local lymph node enlargement or solitary mass, and few systemic symptoms [1,2]

  • MCD presents with two subgroups, human herpesvirus-8 (HHV-8) and idiopathic MCD

Read more

Summary

Background

Castleman disease (CD) are described as an angiofollicular lymph node hyperplasia, and was first reported in 1954 by Benjamin Castleman. The localized form of CD is referred to as unicentric CD (UCD), and the systemic form as multicentric CD (MCD) These entities share pathologic similarities, regarding germinal centers, follicular dendritic and plasma cell prominence and vascularity within lymph nodes, but are featured by specific clinical, pathologic and biological abnormalities [1]. The patient exhibited asymptomatic lesions in different stages of scarring in chiropodactyls, with pitting scars that had appeared initially as bullous lesions and later evolved into small dry ulcers accompanied by nail falls in the past month She reported that the symptoms started one year before and were getting progressively worse. Axillary lymph node biopsy revealed lymphoid tissue with follicular hypoplasia, presenting sinusoidal and medullary infiltration of plasma cells, and absence of granulomas or blast infiltration (Figure 2). There was no recovery of renal function and the patient remained dialysis-dependent

Findings
Discussion
Conclusions
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call